ISTO Technologies, Inc.is both a regenerative medicine and orthopedics company developing innovative cartilage and bone regeneration products for spinal therapy, sports medicine and trauma. ISTO is currently focused on the development of cell-based cartilage platform technology that can be applied to repair and regenerate damaged cartilage in the knee and spinal disc.
ISTO Technologies has a unique pipeline that has demonstrated both clinical progress and market success. With one commercialized product — a bone graft extender and substitute — and two late-stage clinical programs focusing in engineering cartilage tissue for knee and back, respectively, the company is poised to capture an opportunistic yet untapped market. OneMedRadio spoke with CFO Scott Gill about market opportunity, and finding success in a notoriously unfriendly space.
Deteriorating or damaged cartilage is a force to be reckoned with. But ProChon Biotech’s vision is to lead in the innovation of regenerative musculoskeletal technologies.
For many athletes and active individuals, deteriorating cartilage is a mood changer. But Bacterin has developed a regenerative fix for bone cartilage, a move that has never been done before.
We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
RepRegen, formerly known as BioCeramic Therapeutics, is developing a repair and regeneration technology platform designed to mend and repair hard tissue such as bone and soft tissue such as cartilage.
Look out, Spider-Man. A British company has reproduced the silk that spider webs are made out of, for use in repairing bone and joint injuries. Spidrex tissue scaffolds, developed by Oxford Biomaterials, work in tandem with the body’s ability to heal itself…
Copyright © 2024 | WordPress Theme by MH Themes